author-photo

Robert B. Catalano

Drexel University

14

Papers

572

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)

2019 Oncologist
Show All
- Source
- Cite
- Save
Citations (5)
Elderly subgroup analysis of a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Medically Underrepresented Populations In National Cancer Institute (NCI) Sponsored Cancer Clinical Trials: Refining the Calculation of Accrual Targets.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer

2011 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (46)
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer

2010 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (54)
A Comparison of White and African American Outcomes from a Three-Arm, Randomized, Phase III Multicenter Trial of Advanced or Metastatic Non-small Cell Lung Cancer

2010 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Subgroup analysis of African American patients from a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to P plus Cb in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Uridine Diphosphate Glucuronosyltransferase (UGT) 1A1 and Irinotecan: Practical Pharmacogenomics Arrives in Cancer Therapy

2006 Journal of Clinical Oncology
- Peter J. O’Dwyer
- Robert B. Catalano
Show All
- Source
- Cite
- Save
Citations (157)
Minority patients in clinical trials (CT) for advanced non-small cell lung cancer

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): Update of the Alpha Oncology trial (A1-99002L)

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (54)